| Vol. 12.35 – 7 September, 2021 |
| |
|
|
| Lineage tracing using the Neurogenin3 (Ngn3)-CreERT line identified ductal cells expressing the endocrine master transcription factor Ngn3 that were positive for the δ cell marker somatostatin and occasionally co-expressed insulin. [Cell Stem Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| | | Scientists enhanced subcutaneous engraftment by employing a unique vascularization strategy based on ready-made microvessels isolated from the adipose tissue. [Cell Stem Cell] |
|
|
|
| Using massively parallel reporter assays, the authors tested the cis-regulatory effects of single nucleotide polymorphisms associated with type 2 diabetes (T2D) and altered in vivo islet chromatin accessibility in MIN6 β cells under steady state and pathophysiologic endoplasmic reticulum stress conditions. [Nature Communications] |
|
|
|
| Researchers investigated the role of puerarin in endoplasmic reticulum stress-associated apoptosis and explored its underlying mechanism in the mouse insulinoma cell line. [American Journal of Chinese Medicine] |
| |
|
|
| Investigators developed a size switchable nanosystem based on PEG–PLGA nanospheres encapsulated within liposomes for the combined delivery of vactosertib, a TGF-β1 receptor kinase inhibitor, and the cytotoxic drug paclitaxel. [ACS Nano] |
|
|
|
| Kaplan–Meier plotter was used to analyze the prognostic significance of each of the all-known receptor tyrosine kinases to date in immune “hot” and “cold” pancreatic cancers. [Journal of Experimental & Clinical Cancer Research] |
|
|
|
| Long non-coding RNA microarray was adopted to analyze the differential expression of lncRNAs in pancreatic cancer tissues and that in normal peritumoral tissues. [Cell Death & Disease] |
|
|
|
| In a panel of 3D, extracellular matrix based PDAC cell cultures, β1 integrin was inhibited by antibodies or siRNA-mediated knockdown. Together with X-ray irradiation and specific chemotherapies, scientists determined 3D colony formation capacity in therapy-naïve and radioresistant PDAC cultures. [International Journal of Radiation Oncology Biology Physics] |
|
|
|
| Cell counting kit-8 assay and colony formation assay were used to measure the proliferation of pancreatic cancer cells. RNA immunoprecipitation and Western blot were employed for investigation the binding between circPTPN22 and STAT3. [Cancer Gene Therapy] |
|
|
|
| Ectopic expression and knockdown experiments were conducted in pancreatic cancer (PC) cells, PC cells-derived EVs, or mouse xenograft model of PC. [International Immunopharmacology] |
|
|
|
| RT-qPCR was performed to analyze the expression of repulsive guidance molecule BMP co-receptor b antisense RNA 1 (RGMB-AS1) expression. Scientists determined RGMB-AS1 influence on prostate cancer cell malignant behaviors via functional assays. [American Journal of Physiology-Gastrointestinal and Liver Physiology] |
| |
|
|
|
| The clinical relevance of cancer-associated fibroblasts is summarized with an emphasis on their value as prognosis factors and therapeutic targets. [Nature Reviews Clinical Oncology] |
|
|
|
| β cells in the hyperglycemic environment of diabetes have marked changes in phenotype and function that are largely reversible if glucose levels can be returned to normal. A leading hypothesis is that these changes are caused by the elevated glucose levels leading to the concept of glucose toxicity. [Metabolism-Clinical and Experimental] |
|
|
|
|
| Inversago Pharma, Inc. announced that following the receipt of a No Objection Letter from Health Canada on July 29, 2021, it has dosed the first volunteers with INV-202 in its first-in-human Phase I clinical trial, which will evaluate the safety, tolerability and pharmacokinetics of this compound. [Inversago Pharma, Inc.] |
|
|
|
| Fractyl Health, Inc. announced the activation of the tenth clinical site in the company’s pivotal REVITA-T2Di trial taking place across the US and Europe. [Fractyl Health, Inc.] |
|
|
|
|
| October 19 – 20, 2021 Virtual |
|
|
|
|
|
| Benaroya Research Institute at Virginia Mason – Seattle, Washington, United States |
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| European Centre Study Diabetes – Strasbourg, France |
|
|
|
| University Medical Center Utrecht – Utrecht, Netherlands |
|
|
|
| Buck Institute for Research on Aging – Novato, California, United States |
|
|
|
|